2,4,6,8-Nonatetraenamide,N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)- (56281-36-8)

Identification
Name:	2,4,6,8-Nonatetraenamide,N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)-
Synonyms:	2,4,6,8-Nonatetraenamide,N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)-;Molrelinid; Motretinide; Ro 11-1430; Tasmadem; Tasmaderm
CAS:	56281-36-8
EINECS:	260-094-6
Molecular Formula:	C23H31 N O2
Molecular Weight:	353.49774
InChI:	InChI=1/C23H31NO2/c1-8-24-23(25)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(26-7)20(6)19(21)5/h9-15H,8H2,1-7H3,(H,24,25)/b11-9+,13-12+,16-10+,17-14+
Molecular Structure:
Properties
Flash Point:	292.7°C
Boiling Point:	560.3°Cat760mmHg
Density:	0.996g/cm³
Refractive index:	1.55
Flash Point:	292.7°C
Safety Data

Other Product

2,4,6,8-Nonatetraenoicacid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, ethyl ester,(2E,4E,6E,8E)-
2,4,6,8-Nonatetraenoicacid, 6-fluoro-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, methyl ester,(2E,4E,6E,8E)-
2,4,6,8-Nonatetraenamide,N-[(1S)-2-hydroxy-1-methylethyl]-9-[(2S,3R)-3-[(1S,2R,3E,5S)-2-hydroxy-1,3,5-trimethyl-7-phenyl-3-heptenyl]-2-methyloxiranyl]-2-methyl-,(2E,4E,6E,8E)- (9CI)
2,4,6,8-Nonatetraenoicacid, 9-(3-chloro-2,4,6-trimethylphenyl)-3,7-dimethyl-, ethyl ester,(2E,4E,6E,8E)-
2,4,6,8-Nonatetraenoic acid,6-fluoro-9-(4-methoxy-2,3,6-trimethylphenyl)- 3,7-dimethyl-,(2E,4E,6Z,8E)-
(4E,6E,8E)-3-hydroxy-N-{(2E,4E)-6-hydroxy-9-[8-hydroxy-1-(methoxymethyl)-5,7-dimethyl-3,6-dioxo-2-oxa-5-azaspiro[3.4]oct-8-yl]-9-methoxy-7-methylnona-2,4-dien-1-yl}-2,2,4-trimethyl-10-(2-methyl-1,3-oxazol-5-yl)deca-4,6,8-trienamide
ethyl (2E,4E,6E,8E)-9-(2,6-dichloro-4-methoxy-3-methylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate
4,6,8-Decatrienamide,3-hydroxy-N-[(2E,4E,- 6R,7R,9S)-6-hydroxy-9-[(4S,7R,8S)-8- hydroxy-5,7-dimethyl-1,6-dioxo-2-oxa-5- azaspiro[3.4]oct-8-yl]-9-methoxy-7-methyl- 2,4-nonadienyl]-2,2,4-trimethyl-10-(5-oxazolyl)-,(3R,4E,6E,8E)-
2,4,6,8-Nonatetraenoic acid,9-[4-[[[bis(2-chloroethyl)amino]carbonyl]- oxy]-2,3,6-trimethylphenyl]-3,7-dimethyl-,(2E,4E,6E,8E)-
2,4,6,8-Nonatetraenoicacid, 9-(2-chloro-4-methoxy-3,6-dimethylphenyl)-3,7-dimethyl-, ethyl ester,(2E,4E,6E,8E)-
(4E,6E,8E)-3-hydroxy-N-[(2E,4E)-6-hydroxy-9-(8-hydroxy-1,5,7-trimethyl-3,6-dioxo-2-oxa-5-azaspiro[3.4]oct-8-yl)-9-methoxy-7-methylnona-2,4-dien-1-yl]-2,2,4-trimethyl-10-(2-methyl-1,3-oxazol-5-yl)deca-4,6,8-trienamide
2,4,6,8-Nonatetraenoic acid,3,7-dimethyl-9-[2-(nonyloxy)-6-(trifluoromethyl)phenyl]-, (2E,4E,6E,8E)-
2,4,6,8-Nonatetraenamide,9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-
2,4,6,8-Nonatetraenoicacid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2Z,4E,6E,8E)-
b-D-Galactopyranoside,(1S,3'R,4'R,5'R,6'R)-3',4',5',6'-tetrahydro-3',5,7-trihydroxy-4'-[[(2E,4E,8E,10E)-7-hydroxy-8,14-dimethyl-1-oxo-2,4,8,10-hexadecatetraenyl]oxy]-6'-(hydroxymethyl)spiro[isobenzofuran-1(3H),2'-[2H]pyran]-5'-yl,6-[(2E,4Z,6E)-8-hydroxy-2,4,6-decatrienoate] (9CI)
2,4,6,8-Nonatetraenoicacid, 4-fluoro-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-,(2E,4Z,6E,8E)-
2H-Pyran-2-one,6-[(1R,2E,4E,6R,8E)-9-bromo-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-6-methoxy-3-methyl-2,4,8-nonatrienyl]tetrahydro-4-methoxy-, (4R,6R)-
2,4,6,8-Nonatetraenoicacid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6Z,8E)-
(2E,4E,6E)-ethyl 7-((2S,3S,4R,5R)-3-hydroxy-4-((2-methoxyethoxy)methoxy)-2,4,5-trimethyltetrahydrofuran-2-yl)-6-methylhepta-2,4,6-trienoate
2,4,6,8-Nonatetraenoicacid, 3,7-dimethyl-9-(2,4,5-trimethyl-3-thienyl)-, ethyl ester, (2E,4E,6E,8E)-